Featured Research

from universities, journals, and other organizations

PVC as flooring material in childhood is related to asthma 10 years later

Date:
October 24, 2013
Source:
Expertsvar
Summary:
Children who had PVC floorings in the bedroom at baseline were more likely to develop asthma during the following 10 years period when compared with children living without such flooring material. Furthermore, there were indications that PVC flooring in the parents’ bedrooms were stronger associated with the new cases of asthma when compared with child's bedroom. This could be an indication that prenatal exposure is of importance.

PVC flooring. Soft polyvinyl chloride (PVC) is common flooring material. It contains phthalates that are normally released to the surrounding environment.
Credit: © Ingo Bartussek / Fotolia

Children who had PVC flooring in the bedroom at baseline were more likely to develop asthma during the following 10 years period when compared with children living without such flooring material. Furthermore, there were indications that PVC flooring in the parents' bedrooms were stronger associated with the new cases of asthma when compared with child's bedroom. This could be an indication that prenatal exposure is of importance.

Soft polyvinyl chloride (PVC) is common flooring material in Swedish homes used in more than 30% of the bedrooms. Soft PVC includes phthalates that normally are released to the surrounding environment. Phthalates is a group of chemicals with suspected endocrine disrupting properties that may impact on several chronic diseases/disorders such as asthma and allergy. The current study was aimed to investigate if PVC-flooring in the home of children in the age of 1-5 years was associated with the development of asthma in 5-year and 10-year follow-up investigations (n=3,228).

The Dampness in Buildings and Health (DBH) study started in the year of 2000 with a questionnaire to the parents of more than 14,000 children (1-5 years of age) in Värmland, Sweden, with responses from almost 11,000 children corresponding to a response rate of 79%. In this baseline questionnaire we screened for health in the family, lifestyles, building characteristics, etc. In 2005 we made a first 5 year follow up study and 2010 we made a second 10 year follow up, i.e., the data for the current study. The major interest in the follow up studies was to identify children that had developed asthma and other allergic diseases during the period after the baseline investigation.

Children who had PVC floorings in the bedroom at baseline were more likely to develop doctor diagnosed asthma during the following 10 years period when compared with children living without such flooring material. The risk was in several cases more than doubled. Furthermore, there were indications that PVC flooring in the parents' bedrooms were stronger associated with the new cases of doctor diagnosed asthma when compared with child's bedroom. This could be an indication that prenatal exposure is of importance.

This is yet another study indicating health risks related to exposure for chemicals with suspected endocrine disrupting properties (such as phthalates) or products that contain such compounds. We have earlier shown that PVC flooring material is a source for phthalates found in indoor dust, that PVC materials in the home can be related to uptake of one phthalate (butylbenzyl phthalate, BBzP) in infants aged 2-6 months, and that the concentration of phthalates in dust can be related to human uptake of the same phthalates. Further, PVC flooring material as well as indoor dust concentration of phthalates and most recently, prenatal exposure for phthalates can be associated to eczema and asthma in children.

This means that we can follow phthalates from one strong source (PVC), over to indoor dust concentrations, further to human uptake and finally there are findings showing that such exposure might be of importance for asthma and eczema in children.

Our results together with others suggest that PVC flooring and phthalate exposure in early life is a risk for later development of asthma.


Story Source:

The above story is based on materials provided by Expertsvar. Note: Materials may be edited for content and length.


Journal Reference:

  1. Huan Shu, Bo A. Jönsson, Malin Larsson, Eewa Nånberg, Carl-Gustaf Bornehag. PVC-flooring at home and development of asthma among young children in Sweden, a 10-year follow-up. Indoor Air, 2013; DOI: 10.1111/ina.12074

Cite This Page:

Expertsvar. "PVC as flooring material in childhood is related to asthma 10 years later." ScienceDaily. ScienceDaily, 24 October 2013. <www.sciencedaily.com/releases/2013/10/131024102044.htm>.
Expertsvar. (2013, October 24). PVC as flooring material in childhood is related to asthma 10 years later. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2013/10/131024102044.htm
Expertsvar. "PVC as flooring material in childhood is related to asthma 10 years later." ScienceDaily. www.sciencedaily.com/releases/2013/10/131024102044.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins